1575 related articles for article (PubMed ID: 15050318)
21. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
22. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
23. Role of planned neck dissection for advanced metastatic disease in tongue base or tonsil squamous cell carcinoma treated with radiotherapy.
Roy S; Tibesar RJ; Daly K; Pambucian S; Lee HK; Gapany M; Adams GL
Head Neck; 2002 May; 24(5):474-81. PubMed ID: 12001078
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
25. Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy.
Yovino S; Settle K; Taylor R; Wolf J; Kwok Y; Cullen K; Ord R; Zimrin A; Strome S; Suntharalingam M
Head Neck; 2010 Jan; 32(1):46-52. PubMed ID: 19484762
[TBL] [Abstract][Full Text] [Related]
26. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
27. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
28. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
30. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
[TBL] [Abstract][Full Text] [Related]
31. Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer.
Sabatini PR; Ducic Y
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):474-7. PubMed ID: 19786215
[TBL] [Abstract][Full Text] [Related]
32. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
33. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
Mukhija V; Gupta S; Jacobson AS; Eloy JA; Genden EM
Head Neck; 2009 Feb; 31(2):183-8. PubMed ID: 19031407
[TBL] [Abstract][Full Text] [Related]
34. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
Garden AS; Asper JA; Morrison WH; Schechter NR; Glisson BS; Kies MS; Myers JN; Ang KK
Cancer; 2004 Mar; 100(6):1171-8. PubMed ID: 15022283
[TBL] [Abstract][Full Text] [Related]
35. Is neck dissection necessary after induction plus concurrent chemoradiotherapy in complete responder head and neck cancer patients with pretherapy advanced nodal disease?
Da Mosto MC; Lupato V; Romeo S; Spinato G; Addonisio G; Baggio V; Gava A; Boscolo-Rizzo P
Ann Surg Oncol; 2013 Jan; 20(1):250-6. PubMed ID: 22836557
[TBL] [Abstract][Full Text] [Related]
36. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
Villar A; Martinez JC; de Serdio JL
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
[TBL] [Abstract][Full Text] [Related]
37. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
[TBL] [Abstract][Full Text] [Related]
38. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study.
Chougule PB; Akhtar MS; Akerley W; Ready N; Safran H; McRae R; Nigri P; Bellino J; Koness J; Radie-Keane K; Wanebo H
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):58-63. PubMed ID: 10210541
[TBL] [Abstract][Full Text] [Related]
40. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
Brizel DM; Albers ME; Fisher SR; Scher RL; Richtsmeier WJ; Hars V; George SL; Huang AT; Prosnitz LR
N Engl J Med; 1998 Jun; 338(25):1798-804. PubMed ID: 9632446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
